12,132 followers
RT @FrontOncology: New research: Cuproptosis in ccRCC: key player in therapeutic and prognostic targets: Background Classical biomarkers h…
RT @FrontOncology: New research: Cuproptosis in ccRCC: key player in therapeutic and prognostic targets: Background Classical biomarkers h…
New research: Cuproptosis in ccRCC: key player in therapeutic and prognostic targets: Background Classical biomarkers have been used to classify clear cell renal cell carcinoma (ccRCC) patients in a variety of ways, and emerging evidences have… https://t.